NCT06032026View on ClinicalTrials.gov

Study of Biodistribution, Metabolism, Excretion and Brain Uptake of 11C-HY-2-15

EARLY_PHASE1RecruitingINTERVENTIONAL
Enrollment

70

Participants

Timeline

Start Date

August 2, 2023

Primary Completion Date

July 31, 2028

Study Completion Date

July 31, 2028

Conditions
Tauopathies
Interventions
DRUG

11C-HY-2-15 PET

2 hour Positron Emission Tomography (PET) scan using new radiotracer 11C-HY-2-15

DIAGNOSTIC_TEST

brain MRI

brain MRI scan

DIAGNOSTIC_TEST

Amyloid PET scan

PET scan with Florbetaben F18 or 11C-PiB

BEHAVIORAL

Neurological assessments

Neurological assessments, including video interview

Trial Locations (1)

19104

RECRUITING

University of Pennsylvania, Philadelphia

All Listed Sponsors
lead

University of Pennsylvania

OTHER